Drug Shortage Report for APO-LOSARTAN/HCTZ
Report ID | 55807 |
Drug Identification Number | 02371235 |
Brand name | APO-LOSARTAN/HCTZ |
Common or Proper name | LOSARTAN/HCTZ |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-23 |
Actual start date | 2018-07-20 |
Estimated end date | 2018-09-14 |
Actual end date | 2018-09-14 |
Shortage status | Resolved |
Updated date | 2018-09-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-09-15 | English | Compare |
v8 | 2018-09-10 | French | Compare |
v7 | 2018-09-10 | English | Compare |
v6 | 2018-09-04 | French | Compare |
v5 | 2018-09-04 | English | Compare |
v4 | 2018-07-23 | French | Compare |
v3 | 2018-07-23 | English | Compare |
v2 | 2018-07-15 | French | Compare |
v1 | 2018-07-15 | English | Compare |
Showing 1 to 9 of 9